The prevalence, risk factors, and clinical characteristics of insulin resistance in Chinese patients with schizophrenia
Background: Studies have shown that patients with schizophrenia are at a high risk of developing insulin resistance (IR). We investigated the prevalence of IR and its clinical correlates in hospitalized Chinese patients with schizophrenia. Methods: A total of 193 patients with schizophrenia (113 mal...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Comprehensive Psychiatry |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0010440X19300689 |
id |
doaj-c5a05bfd34cd48fa84a952519f4c14d4 |
---|---|
record_format |
Article |
spelling |
doaj-c5a05bfd34cd48fa84a952519f4c14d42020-11-25T01:43:55ZengElsevierComprehensive Psychiatry0010-440X2020-01-0196The prevalence, risk factors, and clinical characteristics of insulin resistance in Chinese patients with schizophreniaChen Lin0Ke Chen1Rongzhen Zhang2Weihong Fu3Jianjin Yu4Lan Gao5Haiqing Ni6Jiaqi Song7Dachun Chen8Department of Psychosomatic Medicine, Beijing HuiLongGuan Hospital, Peking University, Beijing, 100096, PR ChinaBeijing HuiLongGuan Hospital, Beijing, 100096, PR ChinaBeijing HuiLongGuan Hospital, Beijing, 100096, PR ChinaBeijing HuiLongGuan Hospital, Beijing, 100096, PR ChinaBeijing HuiLongGuan Hospital, Beijing, 100096, PR ChinaBeijing HuiLongGuan Hospital, Beijing, 100096, PR ChinaGuangzhou Brain Hospital, Guangzhou, 510450, PR ChinaPeking University Health Science Center, Beijing, 100191, PR ChinaBeijing HuiLongGuan Hospital, Beijing, 100096, PR China; Corresponding author at: Fifth Clinical Department, Beijing HuiLongGuan Hospital, Peking University, Beijing, 100096, PR China.Background: Studies have shown that patients with schizophrenia are at a high risk of developing insulin resistance (IR). We investigated the prevalence of IR and its clinical correlates in hospitalized Chinese patients with schizophrenia. Methods: A total of 193 patients with schizophrenia (113 males and 80 females) were recruited for the study. We collected their demographic and clinical data, including data on their plasma glucose and lipid levels. All patients were rated using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to assess cognitive function, while Positive and Negative Syndrome Scale (PANSS) was used to assess psychopathology. The cut-off value for the homeostasis model assessment of insulin resistance (HOMA-IR) was set at 1.7. Results: The prevalence of IR was 37.82% (73/193). The IR patients had significantly higher waist-to-hip ratio and body mass index (BMI), and higher fasting plasma glucose (FPG), triglyceride (TG), and low density lipoprotein (LDL) levels compared to non-IR patients (all p < .05). Binary logistic regression analysis showed that smoking, BMI, and TG and LDL levels are significant predictors of IR. In addition, correlation analysis showed that IR was significantly correlated with the waist-to-hip ratio, BMI, and LDL level (Bonferroni corrected p < .05). The multivariable linear regression analysis indicated that the BMI and FPG are associated with the IR index. There was no significant difference in IR index between patients who were taking different antipsychotics. Conclusion: We found a high prevalence of IR and its risk factors in Chinese patients with schizophrenia. Active weight control to reduce the BMI and waist circumference and reducing the number of cigarettes consumed, may be essential to decrease the incidence of IR in patients with schizophrenia. Keywords: Schizophrenia, Insulin resistance, Prevalence, Risk factorshttp://www.sciencedirect.com/science/article/pii/S0010440X19300689 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chen Lin Ke Chen Rongzhen Zhang Weihong Fu Jianjin Yu Lan Gao Haiqing Ni Jiaqi Song Dachun Chen |
spellingShingle |
Chen Lin Ke Chen Rongzhen Zhang Weihong Fu Jianjin Yu Lan Gao Haiqing Ni Jiaqi Song Dachun Chen The prevalence, risk factors, and clinical characteristics of insulin resistance in Chinese patients with schizophrenia Comprehensive Psychiatry |
author_facet |
Chen Lin Ke Chen Rongzhen Zhang Weihong Fu Jianjin Yu Lan Gao Haiqing Ni Jiaqi Song Dachun Chen |
author_sort |
Chen Lin |
title |
The prevalence, risk factors, and clinical characteristics of insulin resistance in Chinese patients with schizophrenia |
title_short |
The prevalence, risk factors, and clinical characteristics of insulin resistance in Chinese patients with schizophrenia |
title_full |
The prevalence, risk factors, and clinical characteristics of insulin resistance in Chinese patients with schizophrenia |
title_fullStr |
The prevalence, risk factors, and clinical characteristics of insulin resistance in Chinese patients with schizophrenia |
title_full_unstemmed |
The prevalence, risk factors, and clinical characteristics of insulin resistance in Chinese patients with schizophrenia |
title_sort |
prevalence, risk factors, and clinical characteristics of insulin resistance in chinese patients with schizophrenia |
publisher |
Elsevier |
series |
Comprehensive Psychiatry |
issn |
0010-440X |
publishDate |
2020-01-01 |
description |
Background: Studies have shown that patients with schizophrenia are at a high risk of developing insulin resistance (IR). We investigated the prevalence of IR and its clinical correlates in hospitalized Chinese patients with schizophrenia. Methods: A total of 193 patients with schizophrenia (113 males and 80 females) were recruited for the study. We collected their demographic and clinical data, including data on their plasma glucose and lipid levels. All patients were rated using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to assess cognitive function, while Positive and Negative Syndrome Scale (PANSS) was used to assess psychopathology. The cut-off value for the homeostasis model assessment of insulin resistance (HOMA-IR) was set at 1.7. Results: The prevalence of IR was 37.82% (73/193). The IR patients had significantly higher waist-to-hip ratio and body mass index (BMI), and higher fasting plasma glucose (FPG), triglyceride (TG), and low density lipoprotein (LDL) levels compared to non-IR patients (all p < .05). Binary logistic regression analysis showed that smoking, BMI, and TG and LDL levels are significant predictors of IR. In addition, correlation analysis showed that IR was significantly correlated with the waist-to-hip ratio, BMI, and LDL level (Bonferroni corrected p < .05). The multivariable linear regression analysis indicated that the BMI and FPG are associated with the IR index. There was no significant difference in IR index between patients who were taking different antipsychotics. Conclusion: We found a high prevalence of IR and its risk factors in Chinese patients with schizophrenia. Active weight control to reduce the BMI and waist circumference and reducing the number of cigarettes consumed, may be essential to decrease the incidence of IR in patients with schizophrenia. Keywords: Schizophrenia, Insulin resistance, Prevalence, Risk factors |
url |
http://www.sciencedirect.com/science/article/pii/S0010440X19300689 |
work_keys_str_mv |
AT chenlin theprevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT kechen theprevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT rongzhenzhang theprevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT weihongfu theprevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT jianjinyu theprevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT langao theprevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT haiqingni theprevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT jiaqisong theprevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT dachunchen theprevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT chenlin prevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT kechen prevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT rongzhenzhang prevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT weihongfu prevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT jianjinyu prevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT langao prevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT haiqingni prevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT jiaqisong prevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia AT dachunchen prevalenceriskfactorsandclinicalcharacteristicsofinsulinresistanceinchinesepatientswithschizophrenia |
_version_ |
1725030846123999232 |